SCHEMBL3343814

SCHEMBL3343814

O[C@@H]1C=Cc2c(cc3ccc4cccc5ccc2c3c45)[C@H]1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.41
ERBB2 P04626 1/20 0.41
FYN P06241 1/20 0.41
MAOA P21397 1/20 0.41
ACHE P22303 1/20 0.41
AHR P35869 1/20 0.41
ALDH1A1 P00352 5/20 0.40
HPGD P15428 5/20 0.40
HSD17B10 Q99714 4/20 0.40
CYP3A4 P08684 2/20 0.40
TSHR P16473 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 3/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
CYP1A1 P04798 2/20 0.33
CYP1B1 Q16678 2/20 0.33
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6670237 1.00 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL3343813 1.00 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL6735412 1.00 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL28250000 0.87 ERBB2 (0.32) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL16744739 0.76 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL3344060 0.76 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL6907351 0.76 ALDH1A1 (0.38) CYP1A2ALDH1A1HPGDHSD17B10TSHR
SCHEMBL6907348 0.76 ALDH1A1 (0.38) CYP1A2ALDH1A1HPGDHSD17B10TSHR
SCHEMBL2785557 0.76 ALDH1A1 (0.38) CYP1A2ALDH1A1HPGDHSD17B10TSHR
SCHEMBL12643727 0.75 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100162416-A1 Multi-stage stem cell carcinogenesis STEMLIFELINE, INC. (US) 2010-06-24 US disclosed
WO-2010037134-A2 MULTI-STAGE STEM CELL CARCINOGENESIS STEMLIFELINE, INC. (US) 2010-04-01 WO disclosed
US-20040265807-A1 Isolated polypeptide of given amino acid sequence; expression vectors, host cells, antibodies, agonists, and antagonists; assessing toxicity of test compound; use in diagnosing, treating, or preventing disorders associated with aberrant expression INCYTE CORPORATION 2004-12-30 US disclosed
US-20040054157-A1 Oxidoreductases INCYTE CORPORATION 2004-03-18 US disclosed
US-6323325-B1 Agents that bind to and inhibit human cytochrome P450 2A6 THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2001-11-27 US disclosed
WO-2000004861-A2 AGENTS THAT BIND TO AND INHIBIT HUMAN CYTOCHROME P450 2A6 THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2000-02-03 WO disclosed
US-5358860-A Using peroxide substrate as oxidant THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 1994-10-25 US disclosed
US-4855512-A DEHYDRATION OF 1,2-DIHYDROXY-3-FLUOROCYCLOHEXA-3,5-DIENE SHELL OIL COMPANY (US) 1989-08-08 US disclosed